Yun-Mi Jeong Selected Research

KHG22394

1/2007

A new 2-imino-1,3-thiazoline derivative, KHG22394, inhibits melanin synthesis in mouse B16 melanoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yun-Mi Jeong Research Topics

Disease

7	Melanoma (Melanoma, Malignant) 01/2021 - 02/2006
6	Neoplasms (Cancer) 02/2015 - 12/2006
4	Experimental Melanoma 01/2013 - 01/2007
3	Ischemia 06/2020 - 01/2017
3	Glioma (Gliomas) 08/2014 - 09/2012
3	Carcinoma (Carcinomatosis) 04/2011 - 02/2010
2	Reperfusion Injury 06/2020 - 04/2017
2	Urinary Bladder Neoplasms (Bladder Cancer) 04/2011 - 04/2011
2	Neoplasm Metastasis (Metastasis) 01/2011 - 04/2010
1	Alzheimer Disease (Alzheimer's Disease) 11/2021
1	Inflammation (Inflammations) 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Dysbiosis 01/2021
1	Myocardial Infarction 01/2020
1	Schizophrenia (Dementia Praecox) 04/2017
1	Retinal Dysplasia 04/2017
1	Left Ventricular Dysfunction 04/2017
1	Cardiotoxicity 04/2017
1	Autistic Disorder (Autism) 01/2017
1	Infarction (Infarctions) 01/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Intellectual Disability (Idiocy) 01/2017
1	Microcephaly 01/2017
1	Glaucoma 02/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2014
1	Carcinogenesis 11/2014
1	Wounds and Injuries (Trauma) 07/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2011
1	Vitiligo 11/2005

Drug/Important Bio-Agent (IBA)

4	Horseradish PeroxidaseIBA 02/2010 - 02/2006
4	indoleacetic acid (indole acetic acid)IBA 02/2010 - 02/2006
3	CytokinesIBA 01/2021 - 07/2013
3	Leucine (L-Leucine)FDA Link 08/2014 - 09/2012
2	Proteins (Proteins, Gene)FDA Link 11/2021 - 02/2015
2	Substance PIBA 06/2020 - 01/2020
2	Melanins (Melanin)IBA 01/2013 - 01/2007
2	Monophenol Monooxygenase (Tyrosinase)IBA 01/2013 - 01/2007
2	indole-3-carbinolIBA 12/2011 - 01/2011
2	beta CateninIBA 01/2011 - 04/2010
2	Death Domain ReceptorsIBA 02/2010 - 12/2006
1	Amyloid beta-PeptidesIBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	CollagenIBA 01/2021
1	methylglyoxal bis(3-aminopropylamidinohydrazone)IBA 01/2021
1	Peptides (Polypeptides)IBA 06/2020
1	TachykininsIBA 06/2020
1	salicylhydroxamic acid (SHAM)IBA 06/2020
1	Microphthalmia-Associated Transcription FactorIBA 01/2020
1	Differentiation AntigensIBA 04/2017
1	Exenatide (Byetta)FDA Link 04/2017
1	Carrier Proteins (Binding Protein)IBA 04/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2017
1	Retinaldehyde (Retinal)IBA 04/2017
1	Glucagon-Like Peptide 1 (GLP 1)IBA 04/2017
1	4-(((4-carboxybutyl) (2- (5-fluoro-2-((4'-(trifluoromethyl) biphenyl-4-yl)methoxy)phenyl)ethyl) amino)methyl)benzoic acidIBA 01/2017
1	Soluble Guanylyl CyclaseIBA 01/2017
1	KT 5823IBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Biological ProductsIBA 02/2015
1	ClusterinIBA 11/2014
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 07/2013
1	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 07/2013
1	GinsenosidesIBA 01/2013
1	Cyclic AMP (AMP, Cyclic)IBA 01/2013
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2013
1	AcidsIBA 04/2011
1	Hydroxyindoleacetic AcidIBA 04/2011
1	Photosensitizing Agents (Photosensitizers)IBA 04/2011
1	ArbutinIBA 04/2011
1	Androgen Receptors (Androgen Receptor)IBA 01/2011
1	Epidermal Growth Factor (EGF)IBA 01/2011
1	benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA 04/2010
1	Proteasome InhibitorsIBA 04/2010
1	imidazoleIBA 04/2010
1	Citric Acid (Citrate)FDA LinkGeneric 12/2009
1	KHG22394IBA 01/2007
1	2-imino-1,3-thiazolineIBA 01/2007
1	alpha-MSHIBA 01/2007
1	Free RadicalsIBA 12/2006
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 08/2006
1	QuercetinIBA 11/2005
1	Folic Acid (Vitamin M)FDA LinkGeneric 11/2005
1	AntioxidantsIBA 11/2005

Therapy/Procedure

3	Therapeutics 10/2017 - 12/2006
1	Oral Administration 01/2017